TIGIT and colorectal carcinoma: In line with this, Shao et al. demonstrated that increased frequencies of CD3+TIGIT+ T cells in both peripheral blood and tumor tissue of CRC patients were associated with worse clinical outcome, and that these cells were more abundant than in healthy donors [44].